Cost-effective, flexible and high-yield system for manufacturing cannabinoids
While rare cannabinoids may hold tremendous potential as new treatments for diseases with high unmet medical needs, it is not economically feasible to extract and!-->!-->!-->!-->!-->…
Read More...
Browsing Tag
cannabinoids
Revive Therapeutics: Focused on Infectious Diseases, Psychedelics & CBD
Patent and license portfolio focused on infectious diseases, psychedelics, and CBD
Revive Therapeutics is a life sciences!-->!-->!-->!-->!-->…
BTV News Alert: InMed Advances a Rare Cannabinoid that Could Treat Skin &…
InMed is the first to advance a rare cannabinoid to human clinical trials
InMed Pharmaceuticals is a biopharmaceutical!-->!-->!-->!-->!-->…
InMed Pharmaceuticals: Leading the Way in Rare Cannabinoids
Rare cannabinoids have potential to treat skin and eye diseases
InMed Pharmaceuticals is a leader in developing rare!-->!-->!-->!-->!-->…
Bringing Cannabis to the Wellness Market
CEO, Penny White explains how the company is bringing cannabis into the international wellness market
The Yield Growth!-->!-->!-->!-->!-->…
FSD: Advancing Research and Development
Advancing R&D to fulfill unmet medical needs.
FSD's R&D platform focuses on cannabinoids and their potential for!-->!-->!-->!-->!-->…
A Patent Pending Technology to Enhance Cannabis Extraction
Single-step Extraction=Higher Yields, at Faster Rates
World-Class Extractions provides precision single step mobile!-->!-->!-->!-->!-->…
First to Patent the Production of Cannabinoid Concentrate
CBD & THC Molecules Ready to Infuse Products in October 2019
What Nextleaf is as a molecule factory. They are the first!-->!-->…
New Cannabis Facility Means More Cultivation
" FSD Pharma would have three point nine million square feet of facility to produce 400 thousand kg of cannabis year over year.!-->!-->…
Chris Bunka, CEO of Lexaria Bioscience shares their DehydraTECH technology
“Lexaria Bioscience has the actual opportunity of changing the world. We can do it through saving lives, making health!-->!-->…